| Primary |
| Breast Cancer Metastatic |
54.2% |
| Product Used For Unknown Indication |
18.9% |
| Breast Cancer |
10.6% |
| Breast Cancer Recurrent |
4.8% |
| Pain |
1.6% |
| Premedication |
1.6% |
| Prophylaxis |
1.3% |
| Her-2 Positive Breast Cancer |
1.0% |
| Metastatic Gastric Cancer |
1.0% |
| Bacterial Infection |
0.6% |
| Endometrial Cancer |
0.6% |
| Malignant Melanoma |
0.6% |
| Metastases To Liver |
0.6% |
| Off Label Use |
0.6% |
| Adjuvant Therapy |
0.3% |
| Dry Eye |
0.3% |
| Hypersensitivity |
0.3% |
| Hypertension |
0.3% |
| Hypothyroidism |
0.3% |
| Metastases To Bone |
0.3% |
|
| Death |
37.1% |
| Disease Progression |
15.7% |
| Vomiting |
4.3% |
| Diarrhoea |
2.9% |
| Malignant Neoplasm Progression |
2.9% |
| Myocardial Infarction |
2.9% |
| Off Label Use |
2.9% |
| Pain |
2.9% |
| Paraesthesia |
2.9% |
| Pneumonitis |
2.9% |
| Respiratory Failure |
2.9% |
| Sepsis |
2.9% |
| Skin Reaction |
2.9% |
| Skin Toxicity |
2.9% |
| Tachycardia |
2.9% |
| Tremor |
2.9% |
| Alopecia |
1.4% |
| Blindness Transient |
1.4% |
| Breast Cancer |
1.4% |
| Breast Cancer Metastatic |
1.4% |
|
| Secondary |
| Breast Cancer Metastatic |
67.5% |
| Breast Cancer |
13.6% |
| Product Used For Unknown Indication |
5.5% |
| Prophylaxis |
1.5% |
| Neoplasm Malignant |
1.3% |
| Bone Cancer |
1.1% |
| Pain |
1.1% |
| Vulval Cancer |
1.1% |
| Her-2 Positive Breast Cancer |
0.9% |
| Metastases To Lymph Nodes |
0.9% |
| Premedication |
0.9% |
| Metastases To Liver |
0.7% |
| Nausea |
0.7% |
| Vomiting |
0.6% |
| Vulval Cancer Metastatic |
0.6% |
| Vulvar Adenocarcinoma |
0.6% |
| Adjuvant Therapy |
0.4% |
| Anxiety |
0.4% |
| Bacterial Infection |
0.4% |
| Colorectal Cancer Metastatic |
0.4% |
|
| Death |
61.4% |
| Cardiotoxicity |
12.7% |
| Disease Progression |
4.8% |
| Pain |
2.4% |
| Vitamin D Deficiency |
1.8% |
| White Blood Cell Count Decreased |
1.8% |
| Ejection Fraction Decreased |
1.2% |
| Metastases To Central Nervous System |
1.2% |
| No Therapeutic Response |
1.2% |
| Papilloedema |
1.2% |
| Performance Status Decreased |
1.2% |
| Pneumonitis |
1.2% |
| Pruritus |
1.2% |
| Skin Necrosis |
1.2% |
| Stomatitis |
1.2% |
| Vision Blurred |
1.2% |
| Vomiting |
1.2% |
| Acute Febrile Neutrophilic Dermatosis |
0.6% |
| Blood Potassium Decreased |
0.6% |
| Breast Cancer Metastatic |
0.6% |
|
| Concomitant |
| Breast Cancer Metastatic |
54.2% |
| Breast Cancer |
25.0% |
| Product Used For Unknown Indication |
20.8% |
|
| Back Pain |
16.7% |
| Hypoaesthesia |
16.7% |
| Oral Mucosal Discolouration |
16.7% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
16.7% |
| Pyrexia |
16.7% |
| Scleroderma |
16.7% |
|
